Providing a seamless integration to subspecialty QA review further enhances our single-sign-on Diagnostic Cockpit that enables pathologists to comprehensively review and sign out cases.
Tampa, FL (PRWEB) May 02, 2017
Cancer diagnostics and pathology workflow solution provider Inspirata®, Inc. announced today that it has signed an agreement with QualityStar, LLC to integrate that company’s quality assurance review and quality intelligence services into Inspirata’s anatomic pathology Diagnostic Cockpit and cloud-based telepathology Consultation Portal.
Referred to as “Quality-as-a-Service” (QaaS) for Anatomic Pathology, this unique alternative to in-house quality assurance and case review can be launched through Inspirata’s Diagnostic Cockpit and Consultation Portal. Inspirata’s goal is to facilitate a more rapid and accurate diagnosis in busy pathology departments that may not have the subspecialty expertise or time to conduct the required QA reviews internally.
QaaS helps by enabling external QA reviews to save pathologists’ time, improve diagnostic quality and mitigate the risk of misdiagnosis. The services are provided by subspecialty pathologists working at NCI-designated cancer centers and academic medical centers in the U.S. They cover every tissue type, are double-blinded for pathologist confidentiality and are offered through a secure, HIPAA compliant cloud-based system.
An added benefit of the QA and case review service is a Practice Proficiency Score™ (PPS) derived through QualityStar’s Quality Intelligence Services. The PPS enables pathology departments to track their pathologists’ performance against peer groups. Internal pathologists are measured for longitudinal proficiency and are given expert feedback for continuous improvement and professional development. It also helps pathologists meet certification and CME requirements while gaining valuable clinical quality insights.
“Providing a seamless integration to QualityStar’s subspecialty QA review further enhances our single-sign-on Diagnostic Cockpit that enables pathologists to comprehensively review and sign out cases,” says Inspirata CEO, Satish Sanan. “This is just one more way to save time, help with CMS reimbursement and, most importantly, improve diagnostic proficiency.”
“We are delighted QaaS can be offered as a part of Inspirata’s comprehensive digital pathology workflow solution,” says QualityStar President Monique Spence. “The QualityStar QA consortium supports the shift to outcome-based practices and helps to ensure that pathology departments can gain fast and reliable access to external subspecialty experts who offer a seamless and impartial alternative to internal quality assurance processes—without adding to the pathologist’s workload.”
QualityStar is a quality analytics and case review subscription service for Anatomic Pathology offering confidential third-party quality assurance review with metrics to measure and continuously improve diagnostic proficiency. Approved by the American Board of Pathology (ABP) as a QA program for Part IV Maintenance of Certification, QualityStar draws on a national network of sub-specialists and serves as a low cost and impartial alternative to in-house quality assurance. QualityStar goes beyond the standard peer review concept—ultimately to help pathology practices reduce diagnostic interpretive errors and improve patient care. For more information, visit http://www.qualitystar.net or follow QualityStar on LinkedIn and Twitter.
About Inspirata, Inc.
Inspirata®, Inc. offers the most comprehensive cancer diagnostics workflow solution available for precision diagnosis today. The solution, which employs a unique “solution-as-a-service” business and delivery model, accelerates anatomic and molecular pathology workflows and facilitates whole slide imaging and image analytics, prognostic and predictive assays, remote consultations and tumor boards. This comprehensive solution includes an Enterprise Service Bus (ESB) to help to solve interoperability issues and a Natural Language Processing Engine (NLP) for structuring data. Inspirata amalgamates this structured data into a central multi-institutional and multi-modal big data cancer repository for clinical, research and educational purposes. Its use will extend to physicians, patients, researchers and pharma among others. This comprehensive solution facilitates a modern precision diagnosis to build a strong foundation for precision medicine. For more information, please visit http://www.inspirata.com or contact info(at)inspirata(dot)com.